Predictive factors for early mortality among patients with methicillin-resistant staphylococcus aureus bacteraemia

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 6, 2013, Pages 1423-1430

  Gasch, O ^a   Camoez, M ^a   Dominguez M A ^a   Padilla, B ^b   Pintado, V ^c   Almirante, B ^a   Lepe, J A ^d   Lagarde, M ^e   de Gopegui, E Ruiz ^f   Martinez J A ^g   Montejo, M ^h   Torre Cisneros, J ⁱ   Arna iz A ^j   Goenaga, M A ^k   N Benito, ^l   Rodriguez Bano J ^m   Pujol, M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^j HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^k HOSPITAL DONOSTIA   (Spain)

^l HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^m HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

more..

Author keywords

Bloodstream infections; Empirical antibiotic therapy; MRSA

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PENICILLIN DERIVATIVE; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; CATHETER INFECTION; ENDOCARDITIS; FATALITY; FEMALE; FOREIGN BODY; HOSPITAL INFECTION; HUMAN; INAPPROPRIATE PRESCRIBING; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; PREDICTION; PROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION;

BLOODSTREAM INFECTIONS; EMPIRICAL ANTIBIOTIC THERAPY; MRSA;

AGE FACTORS; AGED; BACTEREMIA; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84880795724     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt016     Document Type: Article

References (47)

1. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report on Communicable Diseases in Europe. 2010. Stockholm: ECDC. http://www.ecdc.europa.eu/en/eaad/documents/eaad- 2011-summary-antimicrobial-resistance-data.pdf (28 December 2012, date last accessed).
2. Benfield T, Espersen F, Frimodt-Moller N et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13: 257-63.
3. Kaech C, Elzi L, Sendi P et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006; 12: 345-52.
4. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005; 52: 113-22.
5. Liao CH, Chen SY, Huang YT et al. Outcome of patients with meticillinresistant Staphylococcus aureus bacteraemia at an emergency department of a medical centre in Taiwan. Int J Antimicrob Agents 2008; 32: 326-32.
6. Lin SH, Liao WH, Lai CC et al. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. J Antimicrob Chemother 2010; 65: 1792-8.
7. van Hal SJ, Jensen SO, Vaska VL et al. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25: 362-86.
8. Soriano A, Marco F, Martinez JA et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillinresistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46: 193-200.
9. Holmes NE, Turnidge JD, Munckhof WJ et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011; 204: 340-7.
10. Soriano A, Martinez JA, Mensa J et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30: 368-73.
11. Lodise TP, Graves J, Evans A et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008; 52: 3315-20.
12. Rojas L, Bunsow E, Munoz P et al. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients. J Antimicrob Chemother 2012; 67: 1760-8.
13. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012; 54: 755-71.
14. Pastagia M, Kleinman LC, Lacerda de la Cruz EG et al. Predicting risk for death from MRSA bacteremia. Emerg Infect Dis 2012; 18: 1072-80.
15. Albur MS, Bowker K, Weir I et al. Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012; 31: 295-301.
16. Honda H, Doern CD, Michael-Dunne W Jr et al. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia. BMC Infect Dis 2011; 11: 335.
17. Fowler VG Jr, Nelson CL, McIntyre LM et al. Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 2007; 196: 738-47.
18. Lalani T, Federspiel JJ, Boucher HW et al. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol 2008; 46: 2890-6.
19. Paul M, Kariv G, Goldberg E et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010; 65: 2658-65.
20. Rodríguez-Bano J, Millán AB, Domínguez MA et al. Impact of inappropriate empirical therapy for sepsis due to health careassociated methicillin-resistant Staphylococcus aureus. J Infect 2009; 58: 131-7.
21. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000; 160: 1001-4.
22. Lodise TP, McKinnon PS, Swiderski L et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-23.
23. Lamagni TL, Potz N, Powell D et al. Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004- 2005. J Hosp Infect 2011; 77: 16-20.
24. Harris AD, Samore MH, Lipsitch M et al. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin Infect Dis 2002; 34: 1558-63.
25. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
26. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
27. McCabe WR, Jackson GG. Gram-negative bacteremia. Clinical, laboratory and therapeutic observations. Arch Intern Med 1962; 110: 856-64.
28. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999; 11: 7-12.
29. Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
30. Garner JS, Jarvis WR, Emori TG et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
31. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
32. Chung M, de Lencastre H, Matthews P et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist 2000; 6: 189-98.
33. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
34. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
35. Milheirico C, Oliveira DC, de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 3374-7.
36. Shopsin B, Mathema B, Alcabes P et al. Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians. J Clin Microbiol 2003; 41: 456-9.
37. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton- Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-32.
38. Gasch O, Ayats J, Angeles DM et al. Epidemiology of methicillinresistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital. Medicine (Baltimore) 2011; 90: 319-27.
39. Cosgrove SE, Sakoulas G, Perencevich EN et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-9.
40. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31: 1170-4.
41. Fang CT, Shau WY, Hsueh PR et al. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. J Antimicrob Chemother 2006; 57: 511-9.
42. Libert M, Elkholti M, Massaut J et al. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect 2008; 68: 17-24.
43. Marchaim D, Kaye KS, Fowler VG et al. Case-control study to identify factors associated with mortality among patients with methicillinresistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010; 16: 747-52.
44. Manzur A, Vidal M, Pujol M et al. Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission. J Hosp Infect 2007; 66: 135-41.
45. Tacconelli E, Venkataraman L, De Girolami PC et al. Methicillinresistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcareassociated strains. J Antimicrob Chemother 2004; 53: 474-9.
46. McGregor JC, Rich SE, Harris AD et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007; 45: 329-37.
47. Moellering RC Jr. What is inadequate antibacterial therapy? Clin Infect Dis 2009; 49: 1006-8.